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ABSTRACT 
Fluorescent Probes to Investigate Homologous 
Recombination Dynamics 
by 
Eric Parker Davenport, Master of Science 
Utah State University, 2016 
 
Major Professor: Dr. Edwin Antony 
Department: Chemistry and Biochemistry 
 
There are multiple mechanisms by which DNA can become damaged. 
Such damage must be repaired for the cell to avoid ill-health consequences. 
Homologous recombination (HR) is a means of repairing one specific type of 
damage, a double-strand break (DSB). This complex pathway includes the 
Rad51-DNA nucleoprotein filament as its primary machinery. Current 
methodology for studying HR proteins includes the use of fluorescently labeled 
DNA to probe for HR dynamics. This technique limits the number of proteins that 
can be involved in experimentation, and often only works as an end reporter. The 
work here aims at improving upon standard techniques by creating two 
fluorescent protein probes. The first probe was developed by directly attaching a 
fluorophore to Saccharomyces cerevisiae Rad51 with the use of click chemistry 
and the incorporation of unnatural amino acids. This probe could function as a 
primary reporter on the formation and dissociation of the Rad51-DNA filament in 
iv 
 
the presence of pro- and anti- HR mediator proteins. The second probe was 
created by labeling the exterior cysteine residues of Plasmodium falciparum 
single strand DNA binding protein (SSB) with a fluorophore via maleimide 
chemistry. This probe acts as a secondary reporter for HR dynamics by signaling 
for when free single stranded DNA (ssDNA) is available. 
(105 pages) 
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PUBLIC ABSTRACT 
Fluorescent Probes to Investigate Homologous 
Recombination Dynamics 
Eric Parker Davenport 
As the average cell’s DNA undergoes roughly 1 million molecular lesions 
per day, learning about one of the repair mechanisms which fixes damaged DNA 
is a worthwhile endeavor. Such work may provide insights into how to treat or 
prevent diseases such as cancers and associated genetic disorders. 
Homologous recombination (HR) is one pathway which is used by cells to repair 
a specific type of DNA damage, double-strand breaks. While HR is a complex 
process involving over 25 different proteins, exactly how HR works, including its 
regulation, is largely unknown. One protein in particular, Rad51, forms a filament 
on the damaged DNA and is critical for the repair process. 
While current research often utilizes labeled DNA as a means of studying 
HR proteins, this work involves the development of two alternative means of 
studying HR. First of all, the Rad51 protein was itself tagged with a fluorophore 
with the use of a technique developed by Dr. Peter Schultz, which involves 
altering one of a protein’s amino acid residues to a synthetic, unnatural amino 
acid. The unnatural amino acid incorporated into Rad51 is then labeled with the 
addition of dye. This results in Rad51 being able to report through fluorescence 
that it is forming a filament with DNA. A second probe was made by taking single 
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strand binding protein, which binds to single stranded DNA (ssDNA), and labeling 
the amino acid cysteine with a fluorophore. This probe works in studying HR by 
signaling when ssDNA becomes available. 
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CHAPTER I 
 INTRODUCTION   
1.1 Abstract 
 Genetic material is essential for all organisms. Damage to DNA, if not 
adequately repaired, can have severe and lasting health consequences. One 
type of damage which DNA may undergo is a double-strand break (DSB). 
Homologous Recombination (HR) is a pathway for fixing DSB’s. To repair the 
damage, a homologous gene is found and aligned with the DSB. Here the 
homologous genetic material is used as a template for the addition of the missing 
nucleotide sequence. Multiple proteins play a role in HR, and notably the Rad51 
protein works as the primary machinery in repair. All life utilizes HR to repair 
damaged DNA. HR is a complex process and is split into the three stages of pre-
synapsis, synapsis and post-synapsis. The development of fluorescently labeled 
protein probes may be useful in the further study of HR and its mediators. 
1.2 DNA Damage and HR 
Living organisms exist as dictated by a specific genetic code. This genetic 
code is constructed of deoxyribonucleic acid (DNA). DNA consists of two strands, 
each made up of many nucleotides. Each nucleotide contains a base (cytosine, 
thymine, adenine or guanine), attached to a deoxyribose sugar, which is itself 
attached to a phosphate at the 5′ carbon. Sequential nucleotides are bound 
together through a phosphodiester linkage, connecting to the 3′ carbon on one 
sugar and to the 5′ carbon on the next. Due to the complementarity from 
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hydrogen bonding of the bases cytosine with guanine and thymine with adenine, 
DNA forms a double helix1 where each strand forms a complement to the other, 
one with 3′ to 5′ directionality and the other with a corresponding 5′ to 3′ 
directionality.   
A genetic code provides the information needed to build and maintain an 
entire organism. In the building of a protein, a sequence of three nucleotides 
codes for one specific amino acid, with the next three nucleotides coding for the 
adjacent amino acid in a polypeptide chain. While the instructions for the order of 
amino acids in proteins are more specifically laid out, the instructions for some 
structures, such as fatty acids, are put forth by coding for the proteins which 
synthesize them, such as with fatty acid synthase.  
In addition to its structure, the genetic code dictates how a system 
functions. This can be seen in how DNA codes for signals that travel to other 
cells, as well as codes for the proteins involved in the sending of damaged or 
unnecessary proteins to the proteasome to be degraded back into basic building 
blocks. Also, the genetic code is vital to the survival of an organism's progeny as 
the next generation's DNA is inherited from the parents. This enhances the 
importance of DNA's stability, as it must be able to replicate over and over in 
order to sustain life.            
While the stability of DNA remains crucial, it can still be damaged in a 
variety of ways. Factors such as alkylating agents, mutagens from the 
environment, electromagnetic radiation, errors in replication, and oxygen radicals 
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can cause significant damage to nucleotide filaments2. Possible resulting 
damages include single stranded DNA (ssDNA) breaks, base mismatches, 
insertion, deletions, pyrimidine dimers, bulky adducts, abasic sites, and 
chemically altered bases2. A variety of damages call for a diverse group of 
mechanisms for DNA repair.  These pathways include direct repair, base-
excision repair, nucleotide excision repair, and mismatch repair2. Fortunately, 
there is often a code readily available to provide instruction during the repair 
process. As long as damage occurs to only one strand of the double stranded 
DNA (dsDNA), the second, undamaged strand can be used as a template for 
repair. 
 DNA can undergo an additional type of damage where both strands break 
apart completely. This is referred to as a double-strand break (DSB). While the 
two sides of the DSB can be ligated back together, which occurs during 
nonhomologous end joining (NHEJ), this obvious approach can result in 
mutations3 as multiple nucleotides are often lost from either side of the DSB as a 
consequence of the initial, break-causing event. This can result in a wide range 
of effects depending on where exactly in the genome the DSB occurs. There is a 
way, however, to fill in this gap with a sequence of nucleotides that should be 
harmonious with the good health of the cell. In a diploid cell, every chromosome 
has a homologous chromosome to pair with it. By aligning the broken 
chromosome with the still intact one, the gene from the undamaged chromosome 
can act as a template for the missing nucleotides in a process called homologous 
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recombination (HR). Other homologous DNA sequences may be found in the 
genome to be utilized for HR. 
All species undergo homologous recombination as a means of DNA 
repair4. HR is a very complex pathway, involving over 30 different genes5. The 
sheer size of a nucleus alone, in relation to the size of just a few missing 
nucleotides, creates an enormous obstacle that is successfully overcome in the 
alignment of two homologous sequences.  
HR takes advantage to NHEJ as the lost nucleotide sequences at the 
break are replaced with a nucleotide sequence found in a homologous segment 
of DNA.  Impaired HR function has been linked to diseases, such as breast 
cancer and ataxia telangiectasia6. HR is also seen as an important factor by 
increasing the amount of genetic diversity during meiosis, creating the necessary 
linkage between two homologous chromosomes before the initial meiotic 
division5. HR is used to repair single strand gaps that have resulted from DNA 
damaging agents, the processing of spontaneous damage, or from the collapse 
of a replication fork, and is additionally responsible for proliferation when 
telomeres are absent5.   
Homologous Recombination is encompassed by three different stages: 
pre-synapsis, synapsis and post-synapsis. Figure 1 provides a brief overview of 
HR. After the occurrence of a DSB, the first event during pre-synapsis is the 
resection of both ends of the break to form 3′ single stranded overhangs. This is 
performed by specialized nucleases.  
5 
 
Although homologous recombination is complex and involves over 25 
proteins7, one specific protein appears to be especially central to its execution. A 
recombination protein, termed Rad51 in yeast, forms a nucleoprotein filament 
along the 3′ single stranded tails and the adjacent double stranded DNA (dsDNA) 
(Fig. 2). The 3′ overhangs can be as short as 2 nucleotides in length, and must 
be complimentary to the homologous DNA8. The Rad51-DNA filament drives the 
search for the homologous gene in the cell, and then works in the alignment of 
the break with said gene. Rad51 also functions as a catalyst in the strand 
exchange reaction between homologous sequences of DNA9. 
During the next stage, synapsis, the Rad51-DNA filament performs strand 
invasion with the homologous gene. This results in D-loop formation (Fig. 1d and 
Fig. 2c) between the broken and healthy DNA filaments.  From here the process 
shifts to the third, post-synapsis stage, and two distinct pathways are possible, 
one of which is synthesis- dependent strand annealing (SDSA). Here, following 
the synthesis of the missing sequence, the strand that initially invades the 
healthy DNA is displaced and anneals with the 3′ overhang of the other broken 
strand.3–5,10. SDSA is promoted by various antirecombinases disrupting the D-
loop11. The series of invasion, synthesis, and disengagement can occur 
repeatedly in the repair of the DSB4. SDSA results in no crossover, or the 
transfer of genetic material, between the two homologous genes. The template 
gene remains the same as it was prior to the SDSA, and the only change in  
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Figure 1 | A simple model of Homologous Recombination. a, Some DNA-
damaging event occurs, resulting in a double stranded break. b, A nuclease 
resects the two damaged ends, creating 3′ overhangs. c, Rad51 filaments form 
on the resected ends. d, After alignment, the homologous gene forms a D-
loop and one Rad51-DNA filament performs strand invasion. Synthesis of the 
missing sequence ensues. e, The 3′ overhangs can anneal and complete the 
necessary synthesis. f, The repaired, doubled stranded DNA. 
Strand Invasion 
Pre-synaptic  
Filament 
Resolution 
Repaired DNA 
End Resecting 
DSB Event 
DNA Resolution 
Machinery 
b 
a 
c 
e 
d 
f 
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sequence of the repaired strand are the nucleotides synthesized in order to fix 
the break. 
Figure 2 | The Rad51 filament on a 3′ overhang. a, Portrayed in green is 
a resected end of a DSB with a 3′ overhang. b, The Rad51 filament (orange) 
eventually forms on the resected DNA. Pro- and anti- HR mediator proteins 
will promote either Rad51 filament formation or disassembly. c, Rad51 works 
to align the broken end with the corresponding sequence on the homologous 
gene (red). Afterwards the missing sequence (blue) is synthesized.  
Pro-HR             
Mediator 
Proteins 
Anti-HR             
Mediator 
Proteins 
Strand Invasion 
D-loop Formation 
b 
a 
c 
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 Another option, opposed to the SDSA pathway, is double strand break 
repair (DSBR). Here the second 3′ overhang also engages with the template 
DNA, which results in two Holliday junctions.  This double junction can be 
resolved by branch migration, and the dissolution of a hemicatenane by 
topoisomerase III4,10. The process creates non-crossover products and the 
healthy gene remains unchanged from before to after recombination. In an 
alternative pathway, still under DSBR, a the double Holliday junction is resolved 
by an endonuclease4. The resulting genes may be either non-crossover or 
crossover. Crossover products result in a loss of heterozygosity, and appear to 
occur less commonly in mitotic HR12. Resolvases such as RuvABC may limit 
crossover products through directional cleavage of Holiday junctions.13 Other, 
hypothetical pathways beside SDSA and DSBR exist, such as break-induced 
replication (BIR). Here the amount of nucleotide copied from the healthy 
chromosome increases as the D-loop is converted to a replication fork4. This 
would result in no crossover between the two chromosomes.   
1.3 HR Regulation 
The proper regulation of HR is critical for cell health. One way to control 
HR is by regulating Rad51. Since the Rad51-DNA filament is so central to the 
process of HR, regulating this filament can act as a way to control the level of HR 
in the cell. 
One example of an HR promoter is Rad52. Rad52 binds to Rad51 and is 
necessary for the nucleation of Rad51 on DNA coated with RPA14. Once Rad51 
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nucleates, it begins to polymerize, displacing RPA. Rad55-Rad57 is a 
heterodimer and also an HR promoter. This complex is capable of loading Rad51 
onto RPA coated DNA, and appears to stabilize and protect the Rad51-DNA 
filament15. This is demonstrated by its formation of a co-filament with Rad51, and 
resulting inhibition of SRS2 anti-recombinase activity16. 
An additional HR promoter is the Shu complex. This complex consists of 
the proteins Shu1, Shu2, Csm2, and Psy3. While the role of this complex is not 
clearly understood15, recent evidence suggests that the Shu complex works 
together with Rad52 and Rad55-Rad57 to promote Rad51 filament formation on 
RPA-coated DNA17. 
The Rad54 protein promotes HR by stabilizing the Rad51 filament and 
stimulating strand invasion15, thereby promoting the search for a homologous 
sequence. Rad54 has also been found to dissociate Rad51 from heteroduplex 
DNA following strand invasion, allowing for DNA synthesis to commense18. 
Another protein responsible for regulating Rad51 in HR is p53. p53 is a 
tumor suppressor protein which commonly contains mutations in cancer cells. 
p53 primarily acts as a transcription factor, regulating the expression of various 
target genes. In the case of HR, p53 binds the promoter of the Rad51 gene and 
represses Rad51 expression19. This appears to be promoted under conditions 
with double-strand breaks19. p53 also regulates HR by directly binding to Rad51, 
inhibiting its polymerization20. Tumor repressor and pro-HR mediator BRCA2 
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forms a complex with both p53 and Rad51, and appears to inhibit the 
transcriptional activity of p5321. 
The HR antagonist SRS2 exhibits both anti-recombinase and helicase 
activity. SRS2 works to disassemble the Rad51-DNA filament22.  SRS2, as well 
as helicases Mph1 and Sgs1, appear to favor SDSA over DSBR, thus limiting 
crossover products23,24. Deficiency in the HR promoter BRCA1 has been 
associated with breast and ovarian cancers25. Further research has linked 
defective HR with methylation at the BRCA1 promoter 26. Recent evidence also 
indicates that serine/arginine-rich splicing factor 3 (SRSF3) regulates the 
expression of BRCA1 and RAD51 genes 27. Further proteins not detailed here 
also function in mediating homologous recombination. 
If an inappropriate recombination event occurs, the genomic stability 
becomes threatened. When DSB’s are not correctly or fully repaired, 
carcinogenesis, chromosome loss, chromosomal rearrangements, and apoptosis 
may occur6. A current area of interest in HR includes, in addition to the formation 
and function of the Rad51 filament, how HR regulators effect the different stages 
of DSB repair10,28,29.  
1.4 Rationale for Thesis Research 
 While the enzymes involved in HR have been identified, the precise 
mechanism of how they function to coordinate HR is poorly understood. For 
example, how the cell decides to commit to HR or abort unnecessary HR events 
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is not known. To understand how Rad51 filaments are formed and disassembled 
during HR, a real-time tool to quantitate Rad51 dynamics on DNA is required.  
 Current experimental tools to observe Rad51 dynamics rely on 
fluorescently labeled DNA. In these experiments the fluorescence of DNA is 
monitored and when Rad51 binds to the DNA, an increase in fluorescence 
intensity is observed. Therefore, binding and dissociation of the Rad51-DNA 
filament can be measured. Such fluorophores are often placed at the end of DNA 
(and on short DNA oligonucleotides). Hence the assay reports HR events 
happening only at the ends. The assay is also limited to observing only one 
protein at a time; hence multi-protein HR reactions cannot be reconstituted. To 
overcome such limitations our research focuses on developing fluorescent HR 
proteins which, upon binding to DNA, will display a change in fluorescence. This 
approach will overcome the end-effect and DNA length limitations associated 
with current techniques. 
Hypothesis: Rad51 binds to ssDNA during HR. We hypothesize that 
regions L1 and L2 of Rad51 will undergo conformational changes upon binding to 
DNA. By placing fluorophores at these regions, we hypothesize that changes in 
fluorescence upon ssDNA binding can be visualized. To help test these 
hypotheses, the following specific aims will be addressed.  
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Aim 1: Create a probe for the Rad51-DNA filament by incorporating the 
unnatural amino acid 4-amino-l-phenylalanine in place of specific amino acid 
residues in Saccharomyces cerevisiae Rad51. 
Aim 1a: Specifically investigate positions on loops L1 and L2 of 
ScRad51 which, following labeling with an alkyne fluorophore, will 
result in fluorescently labeled protein which displays a change in 
fluorescence emission intensity upon filament formation. 
Aim 1b: Develop a UAA probe with a fluorescent label near the N-
terminus of ScRad51, to be used for future FRET and single 
molecule designs.  
 
Aim 2: With Plasmodium falciparum single strand DNA binding protein 
(SSB), develop a probe which, when labeled with a maleimide 
fluorophore, will act as a signal for unbound, single stranded DNA 
(ssDNA) by undergoing a change in fluorescence emission intensity upon 
binding. 
 
The ability to visualize Rad51 filament formation on, and dissociation from, 
DNA in real time would be very useful in the study of homologous recombination. 
This could act as an indicator of what regulator proteins are pro- or anti- Rad51-
DNA filament formation, and thus which proteins are pro- or anti- recombinases. 
While classifying a protein or a system, it is useful to get real-time data, rather 
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than waiting for reactions to reach equilibrium prior to data being taken. Quick, 
real-time analysis of molecular interactions not only provides kinetic detail, but 
can give insights into the reaction mechanism. Such real-time experiments could 
also function to determine the rate of Rad51 filament formation under differing 
conditions. Additionally, single molecule studies could be pursued with this 
technique with the visualization of an individual, labeled Rad51 molecule.  
This work focuses on creating probes that allow for the visualization of 
Rad51 filament dynamics, and focuses specifically on fluorescently labeled 
proteins. A fluorescent label may increase or decrease in signal intensity 
depending on the conformation and environment of the protein it’s attached to. 
By focusing on proteins that undergo both conformational and environmental 
changes, depending on whether a Rad51 nucleoprotein filament forms or 
dissociates, we can develop probes that have the potential to reveal new insights 
into the inner workings of homologous recombination and its regulators.   
New therapeutic approaches might investigate HR proteins as targets for 
treatments of genetic disorders and diseases. As Rad51 expression is increased 
in various cancers, one direction of research for potential therapies has been to 
deliver a gene containing the Rad51 promotor and an open reading frame 
containing a gene detrimental to cell health, such as the diphtheria toxin A (DTA) 
gene, to the patient’s cells30,31. The probes developed here might help further 
elucidate the function of Rad51 filament mediator proteins, indicating which 
proteins/genes could be targeted for therapeutic purposes. 
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CHAPTER II 
DEVELOPING A RAD51 PROBE USING  
UNNATURAL AMINO ACIDS 
2.1 Abstract 
Formation of the Rad51 filament on single stranded DNA (ssDNA) is one 
of the key events in the homologous recombination (HR) pathway and is under 
strict regulation by both pro- and anti- HR mediator proteins. The formation of the 
Rad51 filament and its disassembly dictate the fate of HR and this study has 
focused on developing a real-time assay to quantitate Rad51 dynamics on 
ssDNA. Utilizing unnatural amino acids as an attachment point for fluorophores, 
fluorescent Rad51 probes have been developed which, when bound to ssDNA, 
undergo a change in fluorescence. These studies further the understanding of 
how Rad51 nucleoprotein filaments are formed, and will be useful for future 
studies aimed at understanding how mediator proteins alter its dynamics. This 
information is critical in understanding the role of mediator proteins in HR 
associated defects, and to uncover why mutations in these proteins lead to 
genomic instability, cancers and associated genetic disorders. 
2.2 Introduction 
 As noted in the previous chapter, Rad51 is the primary machinery behind 
homologous recombination. Rad51 exists in both the nucleus and the cytoplasm 
of the cell 32,33. It plays a role in both finding a homologous sequence and 
aligning the double-stranded break for repair. Targeting a probe that allows for 
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the visualization of the nucleoprotein filament formation would be beneficial, as it 
could help understand how pro- and anti- HR mediators function, as well as 
provide insights into how homologous chromosome search, alignment, and 
strand invasion are performed. Taking a closer look at the process of 
homologous recombination further reveals how a Rad51 probe could be useful in 
studying the HR pathway.   
Following the DSB event, and after the two broken ends are resected, the 
single-stranded overhangs are bound by Replication protein A (RPA). The RPA 
protein is a heterotrimer, formed of three subunits: RPA1, RPA2, and RPA3. This 
protein has multiple roles, functioning in replication, recombination and repair for 
eukaryotes34. As ssDNA is susceptible to damage in the cell, RPA works to 
protect the nucleotide strand from degradation. RPA also functions as a sensor 
to signal for the DNA damage response35. Additionally, RPA marks the DNA as 
being single-stranded.  As the bound RPA is displaced from ssDNA, the Rad51 
filament forms simultaneously36. Proteins can be pro-recombinases by promoting 
the dissociation of RPA or promoting the association of Rad51. Anti-
recombinases work in a differing manner, promoting the dissociation of Rad51 
from DNA (Fig. 3).  
2.2.1 Finding the Appropriate Probe Technique 
In the pursuit of studying the formation and dissociation of the Rad51-DNA 
filament, one utilized probe has been DNA labeled with a 3′ or 5′ fluorophore37,38. 
By attaching a 3′ or 5′ fluorophore to DNA, the formation of a nucleoprotein 
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filament can be visualized by an increase or decrease in fluorescent intensity. 
This technique, while it has been used for significant contributions, is limited in 
that the probe is just an end reporter. Additionally, when multiple HR proteins are 
present in an experiment, questions can arise as to which proteins are causing 
the observed change in fluorescence signal.   
Figure 3 | RPA and Rad51. Once the resecting at the ends of a 
double-strand break has taken place, RPA binds the resulting 
single-stranded overhangs. Pro-HR mediator proteins can then 
work to promote the removal of RPA and the formation of a 
Rad51-DNA filament. This is conducive to HR taking place in the 
cell. An anti-HR mediator can work antagonistically to this 
process, assisting in the disassociation of Rad51 and the binding 
of RPA at the 3′ overhangs. 
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To improve upon this technique, Rad51 becomes a candidate for 
conversion into a probe for the study of HR dynamics. The creation of a Rad51 
probe could provide a direct signal for both the formation and dissociation of the 
Rad51-DNA filament. This would provide insights into which proteins are 
promoting or antagonizing HR. In order for Rad51 to have sufficient viability as a 
probe, some quality of the protein must be quantifiable and measured in a 
laboratory setting. Additionally, the signal must change to some degree based on 
environmental, conformational, or spacial changes undergone by the probe.  
Conversely, RPA could also be targeted as a probe. However, as Rad51 
is the central machinery to the HR process, it has been chosen for this study. 
Future work in the Dr. Edwin Antony Lab will investigate the utilization of RPA as 
a probe to study HR. 
 Quantitating fluorescence of the amino acid tryptophan is a technique 
available to measure changes in a protein's environment or confirmation. 
Tryptophan has an aromatic side chain which undergoes fluorescence at an 
excitation of 280nm and an emission of 348nm. However, quantitating tryptophan 
fluorescence for yeast Rad51 is not an option as the protein has no tryptophan 
residues. This technique would also be limited as a current DNA-based assay, as 
multiple proteins cannot be used at once. When measuring tryptophan 
fluorescence does not work as an adequate method for obtaining insights into 
protein dynamics, the addition of a nonnative fluorophore directly to the protein 
may prove beneficial. 
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 A fluorophore functions by absorbing a photon at a given wavelength, 
causing an electron to be excited to a higher energy state. While at this higher 
energy state, the electron may lose some energy by vibrational relaxation. 
Finally, as a photon is emitted from the fluorophore, the electron relaxes to its 
ground state. If any energy was dissipated during the exited state, the emitted 
photon will have lower energy, and a corresponding longer wavelength, than the 
exciting photon. While labeling a protein with a fluorophore can cause the protein 
to fluoresce regardless of its activity level, an added benefit of labeling with a 
fluorophore comes when a change in fluorescence emission intensity is seen as 
activity occurs. This can come about from a change in the microenvironment of 
the fluorophore, or from a conformational change in the protein itself. 
 Multiple concerns can arise when labeling a protein with a fluorophore. 
While the fluorophore might be placed where some change in fluorescence is 
observed as the protein undergoes activity, the ideal placement of the 
fluorophore should not interfere with protein activity or conformation. This can 
arise as an issue especially when the fluorophore, and whatever is attaching it to 
the protein, add large and bulky components to the protein's surroundings39. If 
the label is too intrusive, then the fluorophore will not be a reliable reporter for 
what actually occurs when the fluorophore is absent.   
 A common technique for labeling proteins with a fluorophore is through 
maleimide chemistry. The carbon-carbon double bond of a maleimide group can 
react with a sulfhydryl group, resulting in a stable, nonreversible thioester 
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linkage. A sulfhydryl group is found in the side chain of the amino acid cysteine. 
A protein with exterior cysteine residues can hence have sulfhydryl groups 
available for this reaction. Therefore, if a fluorescent molecule with a maleimide 
group is mixed with this protein, a reaction can occur linking the protein and 
fluorophores. This technique is simple, and does not include bulky molecules 
between the protein and fluorophore to link them together. 
 Creating a fluorescent Rad51 with maleimide chemistry, however, 
becomes problematic as the Rad51 protein in S. cerevisiae contains 8 cysteine 
residues. Several of these residues are important for Rad51 function40,41. As 
cysteine-labeling is not a viable option with Rad51, an alternative method must 
be turned to, although such an approach could be used for other proteins. 
2.2.2 Unnatural Amino Acid Incorporation Technique 
One recently developed technique for labeling proteins has been to 
incorporate an unnatural amino acid (UAA) into the polypeptide chain itself42. 
UAA’s are amino acid derivatives that are not commonly found in nature. A UAA 
may contain a reactive group on its side chain. In order to work as a probe, the 
placement of a UAA must not interfere with the folding, confirmation, or activity of 
the protein of interest. 
The UAA of choice here, 4-azido-L-phenylalanine (4AZP), is a 
phenylalanine derivative and contains an azide group on the 3′ carbon of the 
side-chain benzene ring. A method has been developed by the Shultz group for 
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incorporating UAA’s into proteins43. Furthermore, there has been much work on 
expanding the methods and use involving UAA incorporation in proteins44–47. 
The first step in incorporating an unnatural amino acid is having a 
synthetic tRNA which recognizes a specific codon sequence in the mRNA as a 
point to insert the UAA. Likewise, in order to charge the synthetic tRNA with a 
UAA, a synthetic aminoacyl tRNA synthetase must be developed. Dr. Ryan 
Mehl’s Lab at Oregon State University has developed a synthetic tRNA, as well 
as a synthetic aminoacyl tRNA synthetase, for 4AZP. A pDULE vector coding for 
both the tRNA and the synthetase have been provided by the Mehl group. The 
synthetic tRNA synthetase was designed for the specific purpose of charging the 
synthetic tRNA with 4AZP. The charged tRNA is then capable of reading an 
amber stop codon in the mRNA, not as a site to terminate translation, but rather 
as a specific position to insert 4AZP, allowing for the continuation of translation. 
See Figure 4. It is important to note, however, that the cell still has its natural 
environment where the stop codon can be recognized as a stop codon. Here the 
amber stop codon is recognized at the A site of the ribosome by release factor 1 
(RF1). RF1 then promotes the release of the polypeptide, and translation is 
terminated. This results in a truncated protein product, which does not carry the 
4AZP. 
The next step in the Rad51-UAA synthesis is to decide which codon 
sequence should be altered to an amber stop codon, causing the translated 
product to have an UAA instead of the regular amino acid. Selecting the proper 
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site to change is essential in creating a functional probe. Selecting a residue 
which has a side chain open to the surface allows for the residue to be available 
for the chemical addition of a fluorophore through click chemistry. Additionally, 
the selected residue for UAA incorporation needs to be at a position where the 
attached fluorophore will undergo a change in fluorescence emission intensity 
Figure 4 | Unnatural amino acid incorporation.  In an expression vector 
coding for the protein, an amber stop codon (TAG) substitution is performed 
at the residue of choice for 4AZP placement. This plasmid is then co-
transformed into protein overexpression cells with a second vector coding for 
both the synthetic tRNA and unnatural aminoacyl tRNA synthetase (PDB, 
4JXZ). At the ribosome, the UAG stop codon is read by the synthetic tRNA, 
charged with 4AZP (purple), as a point for 4AZP insertion. Upon successful 
incorporation, translation continues and the resulting Rad51 protein (PDB, 
1SZP) contains 4AZP at the desired residue.  
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upon the formation or dissociation of a Rad51-DNA filament. If no change in 
fluorescence is observed when a nucleoprotein filament forms 
and dissociates, then the probe will not work as a signal for what is happening to 
the Rad51 filament. 
2.2.3 Selecting Residue Sites for Investigation 
 The crystal structure of Rad51 was used to select an appropriate position 
for UAA incorporation. In addition, a high-resolution structure of the homologous 
RecA protein, bound to DNA, was used as a guide for design. By comparing 
crystal structures of RecA48 and Rad5149, homology between the proteins is 
observed (Fig. 5a).  
While structures for Rad51 and RecA are both available, only RecA has a solved 
structure in which it is bound to DNA48. When comparing this structure to the 
crystal structure where RecA is not bound DNA, a conformational change is seen 
in two loops, deemed loops L1 and L2. Rad51, having high homology to RecA, 
has corresponding loops which might also undergo a conformational change 
upon binding to DNA (Fig. 5b). Loops L1 and L2 make good sites for 
investigation of UAA incorporation as they are likely near the space where Rad51 
associates with DNA in the nucleoprotein filament, and could possibly undergo a 
change in confirmation upon DNA binding, as occurs in the RecA-DNA filament 
formation. 
Correspondingly, two sites where investigated on loop L1 (F290 and 
S291), along with one site on loop L2 (F337). A phenylalanine residue was 
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Figure 5 | Selecting DNA-binding residues. a, The crystal structures of 
RecA (brown) and Rad51 (red) are superimposed, highlighting homology. 
b, On the left is the crystal structure for RecA, bound to ssDNA. Loops L1 
and L2 undergo a conformational change upon binding. Rad51, on the 
right, has similar loops L1 and L2, which are disordered when not bound to 
DNA, but may also undergo a change in confirmation upon binding to DNA. 
Crystal structure images were generated from PDB 3CMU, 3LDA, and 
1SZP. 
 
 
a 
b 
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selected in each loop, as 4-azido-L-phenylalanine resembles phenylalanine. This 
is favorable, as a smaller change in structure should cause less disruption in 
protein confirmation and function. 
2.2.4 An Alternative Label for Filament Dynamics 
 An additional site near the N terminus of Rad51 was investigated for UAA 
incorporation (Y16). The N terminal region of ScRad51 is not seen in human and 
bacterial homologs (Fig. 6). ScRad51 has shown the same strand exchange 
activity with and without the N terminus50. Furthermore, the crystal structure of 
Rad51 has only been solved without the N terminal domain included49,50. It may 
be that the N terminal domain is too floppy to result in crystallization. By selecting 
a site that is not associated with protein function, the incorporation of the 
fluorophore may have minimal change on the activity.  
 This probe, as it is not near the hypothesized DNA binding site, is not as 
likely to undergo a large change in fluorescence upon filament formation. 
However, if two appropriate fluorophores are used, fluorescence resonance 
energy transfer (FRET) may be utilized. Under FRET, after a fluorophore is 
excited by an incoming photon, it non-radiatively transfers energy to a nearby 
fluorophore instead of emitting a photon of its own. The second fluorophore is 
then free to emit a photon upon relaxation. In order for FRET to occur, the 
emission wavelength for the first fluorophore must be within the spectrum of the 
excitation wavelength of the second fluorophore. This allows for the proper 
amount of energy to be transferred between the two molecules. Such is the case 
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with the Cy3 and Cy5 fluorophores, and they have been used in previous FRET 
experimentation51–53. 
The distance between two fluorophores in FRET experiments is driven by 
their Foster radius, the distance at which energy transfer efficiency is 50%. 
Previous studies have utilized the Cy3-Cy5 FRET pair with Foster radius values 
of 54-61 Angstroms53. While the crystal structure for ScRad51 does not include 
the N terminus50, the distance between two N termini can be estimated from the 
solved bacterial RecA filament structure48, which is 49.9 angstroms (Fig. 7). This 
distance, being near the Foster radius calculated in previous studies, indicates  
 
Figure 6 | Yeast Rad51 has an extra N-terminal domain. Yeast Rad51 
contains an extra N-terminal domain which is not found in both bacterial 
RecA and Human Rad51. 
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that FRET experimentation may be a worthwhile endeavor with the 16-UAA 
probe, as it is positioned near the N terminus of a homologous protein  
2.3 Materials and Methods 
2.3.1 Mutations 
The ScRad51 DNA sequence was incorporated into a pTXB1 vector, 
using the Nde1 to Nhe1 sites. An EcoR1 site, separating the gene of interest 
from the chitin binding domain (CBD), was removed and replaced with a single 
histidine residue, to act as a linker between Rad51 and the CBD. As pTXB1 
Figure 7 | The RecA-ssDNA Filament. The RecA filament (PDB, 3CMU) 
with monomers in various colors formed on ssDNA (orange). The distance 
between two adjacent N termini is measured to be 49.9 angstroms, ideal for 
FRET experimentation.  
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includes ampicillin resistance, this antibiotic was included in the utilized media 
when cells containing the plasmid were proliferated.  
To alter the genetic coding for the specific amino acids desired to be 
changed to sites for UAA incorporation, site-directed mutagenesis was 
performed. For example, the sequence for phenylalanine 337 (F337) was 
mutated from TTT to TAG (amber stop codon) in this manner. Amber stop 
codons were substituted into the gene with the use of a Q5® Site-Directed 
Mutagenesis Kit (New England Biolabs). Primers were developed with the 
associated NEBBaseChanger™ software (New England Biolabs). All UAA clones 
contained only one TAG mutation as confirmed by sequencing. 
The synthetic aminoacyl tRNA synthetase and the synthetic tRNA were 
both contained in a pDULE vector. The prepared vector was provided to our lab 
by the Dr. Ryan Mehl group at Oregon State University.  
2.3.2 Rad51 Protein Expression  
Rad51 and synthetic tRNA vectors were co-transformed into BL21-AI One 
Shot® Chemically Competent E. coli cells (ThermoFisher Scientific). One colony 
was selected for a 30 mL starter growth, along with 100 µM ampicillin and 50 µM 
spectinomycin.  
The expression media was specifically prepared for this strategy, and 
followed a protocol outlined in Preparation of site-specifically labeled fluorinated 
proteins for 19F-NMR structural characterization54. Components of solutions can 
28 
 
be found in Tables 1-4.  The expression media was combined as outlined in 
Table 1. 
For a 50x M salt solution, the chemicals listed in Table 2 were combined in 
500 mL of MQ H2O. Table 3 includes the components for the 25x Amino Acid 
Mix, which includes every amino acid save tyrosine and cysteine. Tyrosine has a 
low solubility (2.5mM) at neutral pH, while cysteines readily convert to cystines in 
media55. Cysteine thiol groups may also generate the reactive oxygen species 
hydrogen peroxide56. Fortunately, E. coli is capable of synthesizing both of these 
amino acids57.  5g of each included amino acid was added to the mix, and the 
solution was filled to 1 L with MQ H2O for a final concentration of 400 µg/mL. The 
components of the Trace Metal Solution are listed in Table 4.  
The components found in Table 1 were combined with 408 mL of 
autoclaved ddH2O in a 2 L Erlenmeyer flask.  A second flask, with the same 
solution, was prepared as a negative 4AZP control. 2.5 mL of overnight seeding 
culture was added to each flask, along with 500 µL of both 100 mg/mL ampicillin 
and 50 mg/mL spectinomycin.  Each flask was shaken at 250 RPM and 37ºC, as 
optical density at 600 nm (OD600) was monitored with a spectrophotometer up to 
an OD of 2.0.  
To induce protein expression, a final concentration of 400 µM IPTG was 
added to each flask for lac operon induction of the pTXB1-Rad51 and pDULE-
tRNA vectors. Furthermore, 167 µM L-arabinose was added at induction, as the 
gene encoding T7 RNA polymerase in the BL21-AI E. coli cells is controlled by  
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Component Sterilization Amount 
25x Amino Acid Mix  20 mL 
5% Aspartate, pH 7.5 Autoclave 25 mL 
40% (wt/vol) Glucose Autoclave 600 µL 
10 % (vol/vol) Glycerol Autoclave 25 mL 
4 mg/mL Leucine pH 7.5 Autoclave 10 mL 
1 M MgSO4 Autoclave 1 mL 
50x M Salts Autoclave 10 mL 
Trace Metal Solution  100 µL 
Water Autoclave Fill to 500 mL 
 
 
Component 50X Concentration Amount 
NH4Cl 2.5 M 66.9 g 
KH2PO4 1.25 M 85.1 g 
Na2HPO4 1.25 M 85.1 g 
Na2SO4 0.25 M 17.8 g 
Water  Fill to 500 mL 
 
an araBAD operon. 103 mg of 4-azido-phenylalanine was dissolved in 125 µL of 
5 M NaOH, and then brought to a final volume of 4 mL with MQ H2O. All 4 mL of 
the solution were added to the 4AZP positive control flask. The inclusion of 
0.048% (wt/vol) glucose in the expression media helps inhibit leaky plasmid 
expression. E. coli cells will exhibit catabolite repression by consuming available 
glucose prior to the consumption of lactose, xylose or arabinose58,59.This occurs 
as the transcriptional activation of genes involved in catabolizing these lower-
priority sugars is prevented60. Limiting the consumption of arabinose prior to 
induction will inhibit the expression of T7 RNA polymerase, and thus repress the 
expression of the pTXB1-Rad51 and pDULE-tRNA vectors. 
Table 1 | UAA expression media 
Table 2 | Salts for UAA expression. 
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Component Amount 
Alanine 5 g 
Asparagine 5 g 
Aspartic Acid 5 g 
Arginine HCl 5 g 
Glutamic acid sodium 
salt 
5 g 
Glutamine 5 g 
Glycine 5 g 
Histidine HCl H2O 5 g 
Isoleucine 5 g 
Leucine 5 g 
Lysine HCl 5 g 
Methionine 5 g 
Phenylalanine 5 g 
Proline 5 g 
Serine 5 g 
Threonine 5 g 
Tryptophan 5 g 
Valine 5 g 
Water Fill to 1 L 
 
The addition of 4-azido-L-phenylalanine allowed for the synthetic tRNA to 
become charged and to recognize the amber stop codon as a site to add its 
loaded UAA. When no 4AZP was introduced, the amber stop codon was solely 
read as a point to terminate translation.  
After inducing for three hours at 37ºC and 250 RPM, cell growths were 
pelleted at 10,000 RPM for 30 minutes. Supernatant was discarded, and cell 
pellets were stored at -80ºC. 
 
 
Table 3 | 25X amino acid stock 
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Component 
Amount for 30 
mL Stock 
Amount from Stock for 
5,000X solution 
Final Media 
Concentration 
CaCl2 - 2H2O 8.82 g 500 ml 4 µM 
MnCl2 - 4H2O 5.93 g 500 ml 2 µM 
ZnSO4 - 7H2O 8.62 g 500 ml 2 µM 
CoCl2 - 6H2O 1.32 g 500 ml 400 nM 
CuCl2 807 mg 500 ml 400 nM 
NiCl2 777 mg 500 ml 400 nM 
Na2MoO4 - 2H2O 1.45 g 500 ml 400 nM 
Na2SeO3 1.03 g 500 ml 400 nM 
H3BO3 371 mg 500 ml 400 nM 
FeCl3 486 mg 25 ml 10 µM 
Water Fill to 30 mL Fill to 50 mL  
 
2.3.3 Rad51 Protein Purification 
The resuspension of the cell pellet was performed with 50 mL of 
Resuspension Buffer [0.1 M Tris-HCl, pH 8.0, 5 mM EDTA, pH 8.0, 500 mM 
NaCl, 1 M urea, 5 mM 2-mercaptoethanol, 10% wt./vol. sucrose, 10% wt./vol. 
glycerol, and 1 mL Protease Inhibitor Cocktail (2 mM AEBSF, 0.3 μM Aprotinin, 
116 μM Bestatin, 14 μM E-64, 1 μM Leupeptin and 1 mM EDTA)] (Sigma-
Aldrich). This resuspension was transferred to a beaker, and after the addition of 
lysozyme (40mg/100mL), the solution was allowed to stir in a cold room for 30 
Table 4 | Trace metal stock 
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minutes. Afterwards, 6 mL of 100 mM sodium deoxycholate, dissolved in 0.125 M 
NaOH, was added to the lysate. Following an additional 20 minutes on the stir 
plate, sonication was performed to ensure complete cell lysis. Sonication was 
carried out at 50% duty cycle for 1 minute on and 1 minute off. This was 
repeated, and the resulting lysate was spun down at 17,000 RPM for 60 minutes. 
As the soluble protein remained in the supernatant, the pelleted debris 
were discarded. Next, an ammonium sulfate pellet precipitation was performed. 
Increasing the ammonium sulfate concentration, and thus the concentration of 
ions, to high levels will decrease the solubility of proteins61. Proteins which 
aggregate more easily salt-out at lower concentrations of ammonium sulfate than 
proteins with higher solubility62.  
For this step, the supernatant was transferred to a beaker and placed on a 
stir plate at 4ºC. 0.24g/mL ammonium sulfate was added to the supernatant 
slowly over a period of 15 minutes while stirring, forcing the Rad51-CBD fusion 
protein to precipitate out of the solution (Fig. 8).  After an additional 20 minutes, 
the solution was spun down at 10,000 RPM for 30 minutes.  
The ammonium sulfate pellet was resuspended in 25 mL of AS 
Resuspension Buffer (20 mM Tris-HCl, pH 8, 0.5 M NaCl, 0.1 mM EDTA, 10% 
glycerol, and 0.1% TritonX100). 10 mL of Chitin Bead Slurry (New England 
Biolabs) was prepared with two MQ H2O washes and three AS Resuspension 
Buffer washes. The 10 mL of Chitin Bead Slurry was then combined with the 25  
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mL of resuspended protein in a 50 mL falcon tube, and shaken at 4ºC for 3-5 
hours.  
Next the beads were spun down at 4,000 RPM for 5 minutes. After careful 
removal of the supernatant, the beads were washed with AS Resuspension 
Buffer four times. Finally, 30 mM Dithiothreitol (DTT) AS Resuspension Buffer 
was prepared, 5 mL of which was combined with the beads and shaken at 4ºC 
overnight. 
Figure 8 | Ammonium sulfate precipitation of Rad51. Upon the 
gradual addition of 0.24g/mL ammonium sulfate to the clarified lysate 
(Lysis Sup.), Rad51 is salted out of solution as a precipitate (AS Pellet), 
while multiple undesired proteins remain in solution (AS Sup.). 
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The following morning, the beads were again spun at 4,000 RPM for 5 
minutes. The supernatant, containing the purified protein, was removed. Further 
24 hour reactions with 30 mM DTT AS Resuspension Buffer were performed for 
a total of five elutions. The chitin elutions were pooled and concentrated using a 
10 kDa concentrator (Pall Life Sciences). 
It is important to note the significance of the chitin binding domain in 
purifying the probe. Purifying out the Rad51UAA from the truncated Rad51 
product (where the amber stop codon was recognized by the release factor as an 
amber stop codon) presents a concern, as both proteins can behave similarly 
through purification steps. However, the truncated product will not have the C-
terminal chitin binding domain, as translation stops prior to the coding for this 
domain. Hence, no truncated Rad51 protein product should bind to a chitin 
column. This technique works to separate out the Rad51 products (Fig. 9). After 
cleaving the CBD, the purified Rad51UAA can be eluted. 
2.3.4 Fluorescent Labeling 
Once concentrated, the protein, in buffer, was mixed with 10 molar excess 
of either Click-IT® Alexa Fluor® 555 DIBO Alkyne Copper-free fluorophore 
(Molecular Probes) or DBCO-Cy3 for Copper-free Click Chemistry (Sigma), both 
of which had been resuspended in Dimethylsulfoxide (DMSO). Click chemistry 
reactions are selective, and proceed well in water63. The labeling reaction was 
covered in aluminum foil, and rocked at 4ºC for 8 hours.  
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Figure 9 | Rad51 purification with a chitin binding domain. a, An 8% SDS 
page gel displaying the expression and chitin bead purification of Rad51. The first 
lane is marker. The next two lanes show protein expression in uninduced and 
induced cells, where there is no introduction of 4AZP. The two lanes following 
display, respectively, the same conditions, except 4AZP is introduced at 
induction. The last two lanes include samples loaded onto, and cleaved from, a 
chitin bead column. b, A schematic representation of the Rad51 protein. Every 
Rad51UAA construct has undergone a point mutation to code for a stop codon at 
the insertion point for the UAA. i, When the Rad51 successfully has the UAA 
incorporated, translation will not stop until after the inclusion of a chitin binding 
domain. This is seen in the above gel at 75 kDa. ii, After cleavage by DTT, the 
Rad51UAA (42 kDa) elutes from the Chitin column. iii, When the stop codon is 
read by the cell as a stop codon, not as a site for UAA incorporation, a truncated 
Rad51 protein is produced (37 kDa). This protein is unable to bind to a Chitin 
column. 
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Labeled Rad51 protein was next ran over a P6 Bio-Gel size exclusion 
column (Bio-Rad). Rad51 Size-Exclusion Buffer (20 mM Tris-HCl pH 7.5, 10% 
glycerol, 0.5 mM EDTA, 1 mM 2-mercaptoethanol (BME), and 100 mM NaCl) 
was used to equilibrate and run the column. After labeled protein entered the gel 
by gravity, Rad51 Size-Exclusion Buffer was ran through the column at a rate of 
0.3 mL/minute. The appropriate fractions, as indicated by an 8% SDS-PAGE gel, 
were pooled and concentrated in a 10 kDa concentrator (Pall Life Sciences) to 
provide purified Rad51-Alx555 or Cy3. 
2.3.5 Synthesis of 4-Azido-L-phenylalanine 
 A common barrier to the use of unnatural amino acids is their high cost 
and low availability64. As the purchase of 4-Azido-L-phenylalanine (4AZP) can be 
expensive at low quantities, an attempt was made to synthesize this unnatural 
amino acid from the precursor 4-amino-L-phenylalanine (4AMP). 4AMP is 
available in bulk, and at a substantially lower cost. Having a sufficient supply of 
4AZP is critical in developing Rad51-UAA probes. During the expression of a 
Rad51-UAA probe, the synthetic tRNA, being responsible for the incorporation of 
4AZP into the polypeptide chain, could read any amber stop codon in the mRNA 
undergoing translation as a site to insert 4AZP. Therefore, 4AZP must be 
supplied in excess during the expression to allow for it to be incorporated into a 
significant amount of Rad51.  
The following method is specifically for 4AZP synthesis from 4AMP with a 
FMOC (Fluorenylmethyloxycarbonyl) blocking group (Fig. 10) attached to the  
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Figure 10 | Synthesis of 4-azido-l-phenylalanine. FMOC-4-amino-l-
phenylalanine is converted into the intermediate, (2-((((9H-fluroen-9-
yl)methoxy)carbonyl)amino)-3-(4-Azidophenyl)propanic acid where the side 
chain amino group has been altered to an azide, by the acidic addition of nitrate 
and azide. This stable intermediate is further synthesized to 4-azido-l-
phenylalanine by the removal of the FMOC blocking group by piperidine 
dissolved in DMF. Images were generated at pubchem.ncbi.nlm.nih.gov 
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amino group of the unnatural amino acid. A blocking agent is necessary to 
ensure that, during the first step of synthesis, an unwanted reaction does not 
proceed with the amino acid's backbone amino group. The Dr. Tom Chang Lab 
at Utah State University assisted in developing, and carrying out, this protocol. 
Synthesis was performed with 5 grams of starting material, as larger-scale 
reactions gave smaller yields. All reactions were mixed and carried out in a fume 
hood. 
With 5 g of starting material, 50 mL of H20 was used as a solvent to give a 
4AMP concentration of 12.42 mM. Much of the starting material remained solid. 
After the addition of 11.2 mL concentrated HCL (37% volume per volume), the 
starting material dissolved completely into solution. This was followed by cooling 
to 4˚C and the addition of NaNO2 to a concentration of 12.42 mM (giving a 1 : 1 
ratio with the 4AMP), which was first dissolved in 10 mL water. Following 10 
minutes of stirring, NaN3 (14.49 mmol, providing a 1.2 : 1 ratio with 4AMP) was  
added, slowly and cautiously, over a period of 10 minutes, while still stirring. The 
solution was stirred in the fume hood, overnight, at room temperature. On 
occasion, gradual addition of NaN3 resulted in the formation of a foam, 
preventing proper mixing of the compounds. When this occurred, a small volume 
of ethyl acetate (approximately 5 mL) was added to the solution, bringing the 
foam back into solution and allowing for proper mixing. 
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Azides, whether organic or inorganic, can be very sensitive and explosive 
with minimal energy input. Therefore, the addition of an azide must be performed 
under extreme caution.  
The following morning, a white precipitate could be observed. Next, the 
solution underwent three 100 mL ethyl acetate extractions. With each extraction, 
the ethyl acetate was mixed with the reaction in a 500mL seperatory funnel. The 
solution was agitated by manual shaking, with frequent breaks to alleviate the 
positive pressure built inside the funnel. The extractions were combined and 
washed with 50 mL of H20 twice, and once with 50 mL of brine solution. The 
organic layer was collected and dried with anhydrous MgSO4 (to remove any left-
over H2O), although Na2SO4 could also be used. Following a filtration to separate 
out the drying-salt, the removal of ethyl acetate was performed with the use of a 
rotovap apparatus. The product formed was a white powder that was allowed to 
dry overnight (under negative pressure). The resulting product was dry (2-((((9H-
fluroen-9-yl)methoxy)carbonyl)amino)-3-(4-Azidophenyl)propanic acid (Fig. 10). 
Weighing the dried intermediate gave a product yield of 76.2%.  
Following the drying of this intermediate product, it was dissolved in 9 mL 
of DMF (dimethylformamide). After the compound was completely dissolved, 9 
mL of piperidine, in 27 mL DMF, was added. The solution was allowed to stir 
overnight at room temperature. The next morning a white-beige precipitate of the 
final product was observed. This precipitate was collected using a filtered Hirsh 
funnel, and afterwards washed with 25 mL of DMF. The resulting purified product 
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was white, and dried on the same funnel under vacuum. After 2-3 days the 
product was removed from the filter paper by scraping with a spatula. The final 
yield of the synthesized 4AZP was 52%. A C-13 NMR of the final product is 
shown in Supplementary Figure 1. 
2.3.6 Stopped flow Instrumentation 
 Stopped flow instrumentation was utilized to obtain real time data for the 
probes. The basic setup of a Stopped flow device has two syringes containing 
sample solutions (Fig. 11). A drive force combines the two samples in a mixer 
compartment, which quickly arrive at the cell.  A light source penetrates through 
the cell, and absorbance can be measured at an angle of 180 degrees, while 
fluorescence can be detected at 90 degrees. After the period of data collection 
for the reaction has subsided, the sample is discarded from the cell. A stopping 
syringe helps control the volume that is mixed from the two syringes. 
2.4 Results and Discussion 
2.4.1 Labeled Probes 
The first probe developed was the Rad51 337-UAA. The successful 
fluorescent labeling of this probe, completed through click chemistry with an 
alkyne Alx555, is shown in Figure 12. Coomassie stain and fluorescent images of 
the same gel show that the Alx555 was indeed incorporated. Next, the additional 
Rad51 residues F290, S291, and Y16 were successfully mutated, expressed, 
purified, and labeled with Alx555 alkyne dye (Fig. 13-15).  
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2.4.2 Rad51-UAA Stopped flow Experiments 
A Stopped flow experiment can yield helpful data, as the two solutions 
may contain interactive species (such as Rad51 in one well and DNA in the 
other) that undergo an activity upon mixing. This technique is specifically useful 
when an activity occurs that results in a change in the absorbent or fluorescent 
characteristics of the two samples. A benefit of employing Stopped flow 
technique is that the data can be measured nearly instantaneously from mixing.  
Figure 11 | An overview of a Stopped flow experimental setup. Two 
samples are loaded, one into syringe A and one into syringe B. A drive forces 
equal amounts from both syringes, into the mixer and then to the cell where 
a light source, at a given wavelength, penetrates the mixed solution. An 
absorbance detector is set up at a 180º angle from the incoming light, while a 
fluorescence detector is set at 90º. A stopping syringe helps control the 
volume mixed in each run. 
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Coomassie Fluorescence 
Figure 12 | Fluorescent labeling of Rad51-337-4AZP. a, The placement 
of the probe at the disordered loop L2. b, Both Coomassie and fluorescent 
images were taken of the same 8% SDS PAGE gel. Rad51-337-4AZP is 
viewable in the Coomassie stain image, regardless of whether or not a 
fluorophore has been added. The fluorescent image indicated that the dye 
(Alx555) has successfully been linked to the probe. Structure was 
generated from PDB 3LDA. 
a 
b 
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Figure 13 | Fluorescent labeling of Rad51-290-4AZP. a, The probe is 
placed at the disordered loop L1. b, Coomassie and fluorescent images of 
the same 8% SDS PAGE gel. Rad51-290-4AZP is seen in the Coomassie 
image, regardless of fluorophore incorporation. The fluorescent image 
demonstrates that the probe has been successfully labeled with the 
fluorophore (Alx555). Structure was generated from PDB 3LDA. 
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Figure 14 | Fluorescent labeling of Rad51-291-4AZP. a, The placement 
of the probe at the disordered loop L1. b, Coomassie and fluorescent 
images of the same 8% SDS PAGE gel. Rad51-291-4AZP is seen with 
Coomassie stain, regardless of whether or not a fluorophore has been 
added. Successful addition of Alx555 is seen in the fluorescence image. 
Structure was generated from PDB 3LDA. 
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2.4.2 Rad51-UAA Stopped flow Experiments 
kDa 
55 
35 
70 
Coomassie Fluorescence 
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b 
Figure 15 | Fluorescent labeling of Rad51-16-4AZP. a, The placement of the 
probe at N terminus. b, Coomassie and fluorescent images of the same 8% 
SDS PAGE gel. Rad51-16-4AZP is seen with Coomassie stain, regardless of 
whether or not a fluorophore has been added. The fluorescence image indicates 
that the dye (Alx555) has been successfully incorporated. Structure was 
generated from PDB 3LDA. 
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This can provide the kinetic parameters of an interaction, as well as provide 
insights into what could be occurring in the reaction mechanism. 
The first Stopped flow experiment utilizing the Rad51 probe was 
performed to compare the binding behavior of the Rad51-337-UAA with the wild 
type version of the protein (Fig. 16a). Experiments were performed with Stopped 
flow instrumentation, as displayed in Figure 11. Syringe A held dT79 ssDNA with 
a Cy3 fluorescent label on the 5′ end, ATP, and reaction buffer (50 mM Tris-HCl 
pH 7.5, 50 mM NaCl, and 10 mM MgCl2). Syringe B contained wild type Rad51 
and buffer. Upon mixing, a change in the Cy3 fluorescence was observed. A trial 
of the experiment followed with newly synthesized Rad51UAA replacing the wild 
type Rad51. As observed in the data (Fig. 16a), the Rad51UAA shows similar 
fluorescence quenching behavior as the wild type. This indicates that the 
incorporation of 4AZP does not alter Rad51 filament formation.  
Next, a second Stopped flow experiment included Rad51-337-Alx555 and 
buffer in one syringe, with ATP and buffer in the other (Fig. 16b). Fluorescence 
signal strength was recorded upon mixing. To measure the change in 
fluorescence emitted by the probe upon filamentous activity, the same conditions 
were repeated, save with dT70 DNA included in the second syringe. As 
displayed in the figure, a change in signal strength is observed when DNA is 
available. This intensity change comes about as the Rad51 filament forms on 
DNA. Because it exhibits a change in signal upon filament formation, the 
Rad51UAA could potentially act as a probe for when HR is being promoted (and  
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hence undergoing filamentous activity) or antagonized (and the filament is being 
disassembled) by mediator proteins. This experiment was repeated with Rad51-
290-Cy3, Rad51-291-Cy3, and Rad51-337-Cy3 (Fig. 17). As the seen in the  
Figure 16 | Rad51-337-4AZP DNA binding. a, Displayed are 
identical binding kinetics for both wild type Rad51, and Rad51 
with 4AZP incorporated. b, The fluorescence of the Rad51-
4AZP-Alx555 protein changes upon binding to single 
stranded dT70 ssDNA. 
a 
b 
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figure, a change in fluorescence emission intensity is observed when Stopped 
flow reactions include DNA. These preliminary experiments indicate that the 
three probes are providing a change in signal upon DNA binding, allowing for the 
visualization of Rad51-DNA filament formation.  
Figure 17 | Rad51-4AZP-Cy3 Stopped flow experiments. 
These experiments indicate a change in fluorescence emission 
intensity for the probes a Rad51-337-Cy3, b Rad51-290-Cy3, and 
c Rad51-291-Cy3 upon binding to dT70 DNA. 
c b 
a 
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2.5 Future Work 
All Rad51 probes will have their activity levels measured in comparison to 
wild type protein. This will be performed by gel mobility shift assays where the 
Rad51 protein catalyzes a strand exchange reaction between plasmid DNA with 
a shorter, complimentary sequence of phosphorus-32 labeled DNA. To be 
accurate reporters of HR filament dynamics, Rad51-4AZP-fluorophore probes 
must demonstrate activity at the same level as the wild type. This experiment is 
further explained in Chapter 4. 
 The 16-4AZP probe will be labeled with two separate fluorophores, Cy3 
and Cy5, and used for FRET experimentation. By having equal amounts of each 
fluorophore-probe, FRET interactions will exist upon filament formation and some 
of the probe will exhibit a signal. When Rad51 monomers are not interacting, the 
distance between Cy3 and Cy5 will be too great in relation to Foster radius (54-
61 Angstroms53) for FRET to occur. This experiment will be performed with the 
use of a fluorometer. See Figure 18 for a model of the proposed experiment. 
Initially, Rad51-16-Cy3 and Rad51-16-Cy5 will be incubated with ATP, all in 
excess. A baseline of FRET signal will be taken, after which ssDNA will be 
introduced to the system. Upon addition of the oligonucleotide, FRET signal 
should increase as many of the individual proteins making up the filament will 
have an adjacent protein with a different fluorophore which is compatible for 
FRET. Once all available ssDNA has been bound, a plateau should be seen in 
the FRET signal. The same experiment done with ssDNA of various lengths will 
 
 
 
 
Figure 18 | An overview of a proposed FRET experiment. As DNA is mixed with ATP, along with Rad51-
Cy3 and Rad51-Cy5, an increase in FRET signal should be seen as the Rad51-DNA filament forms. After the 
signal is saturated, as all DNA is bound, the introduction of SRS2 will disassembly the filament and RPA will 
be allowed to bind the free DNA. 
5
0
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provide rates of filament formation as a function of length (in base pairs), and the 
rate of formation (in base pairs s-1) can be extracted.  
Next, RPA will be introduced. Initially, no change should be observed in 
the FRET signal. Finally, SRS2, an anti-recombinase, is added. SRS2 works to  
dissociate the Rad51 filament37, allowing RPA to bind the free ssDNA. 
Accordingly, the FRET signal should then fall back to baseline levels once SRS2 
has fully removed all Rad51 filaments. Similarly, to the addition of ssDNA, the 
slope of the data as the signal falls, from the point of SRS2 introduction to 
reaching near-baseline levels, provides a rate for filament dissociation.   
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CHAPTER III 
A SECONDARY FLUORESCENT PROBE WITH PLASMODIUM 
FALCIPARUM SINGLE STRAND DNA BINDING PROTEIN 
3.1 Abstract 
DNA’s integrity is vital to the health of the cell, and must be heavily 
protected. At instances where DNA is single stranded (ssDNA), it becomes more 
vulnerable to damage as it has lower stability. Single strand DNA binding protein 
(SSB) works to protect single stranded DNA from degradation and damage. 
Plasmodium falciparum SSB forms a tetramer in solution and demonstrates only 
one binding mode. In this work, PfSSB is converted into a fluorescent probe for 
unbound ssDNA by labeling it with a maleimide-coumarin fluorophore. Attaching 
a fluorophore to PfSSB results in a probe that quickly associates with ssDNA, 
and functions to monitor both the helicase and anti-recombinase function of the 
homologous recombination protein, SRS2.  
3.2 Introduction 
The single strand DNA binding protein is necessary in every domain65. As 
the name suggests, this protein binds to free ssDNA in the cell, doing so 
independent of sequence66. SSB works to protect DNA from being degraded. 
This protein provides a significant function by binding ssDNA during DNA 
metabolism. SSB makes for a positive candidate to be converted into a probe 
which quantifies when free ssDNA is available in the cell, as it is both commonly 
found and binds with very high affinity to ssDNA. 
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E. coli SSB forms a tetramer67,68, and has been utilized as a probe for 
helicase activity by binding free ssDNA that has been unwound by said 
helicase69. Upon binding to ssDNA, the level of intrinsic tryptophan fluorescence 
of the SSB tetramer is altered. The fluorescence change occurs as the ssDNA 
alters the immediate microenvironment of the exterior tryptophans on each 
subunit. 
While intrinsic tryptophan fluorescence can be a useful technique to 
measure SSB-ssDNA binding, the probe was improved upon by the addition of a 
fluorophore70. This labeled probe undergoes a greater change in fluorescence 
upon binding to ssDNA than the exterior tryptophans, producing greater 
sensitivity in experiments.  
Interestingly, the E. coli SSB tetramer does not always bind the same 
number of nucleotides71. Depending on the NaCl concentration, two binding 
states have been identified, one where the tetramer associates with 65 
nucleotides at high NaCl concentration, and another where the SSB associates 
with 35 nucleotides at lower NaCl concentrations72. A similar probe has recently 
been developed with the species Bacillus subtilis73. Both of these SSB probes 
share a similarity in that they exhibit differing binding modes dependent upon salt 
concentration.  
The differences between the two binding modes create an issue in 
experiments. The buffer conditions must be regimented. Also, if multiple proteins 
are present in a reaction with the probe, it must first be ruled out that these 
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proteins are not affecting the binding mode of SSB. Both of the aforementioned 
probes rely on mutations to introduce novel cysteines to the protein. Changing 
the amino acid residue at a given sight is fundamentally invasive, and can have 
unforeseen effects on the protein’s activity. 
SSB makes for a good candidate to study HR dynamics for multiple 
reasons. Because it binds DNA with a high reported affinity (1010 M-1)72, it can act 
as a reporter for when a protein, such as Rad51 or RPA, is removed from ssDNA 
(as long as it is not competing either protein off of the ssDNA). As pro- and anti- 
recombinases can act by directly promoting or removing the Rad51 filament, 
SSB could act as a second messenger, indicating which proteins are removing 
Rad51 from ssDNA. This can be done by introducing SSB and proteins thought 
to be anti- recombinases to a preformed Rad51-ssDNA filament. If the SSB 
probe demonstrates a change in fluorescence, this would indicate that it has 
bound to ssDNA, and hence that the presumed anti- recombinase works to 
directly dissociate the Rad51-DNA filament. Alternatively, any change in 
fluorescent signal could be brought about by protein-protein interactions involving 
SSB. Therefore, proper controls should be  
performed to ensure that such an interaction is not taking place between SSB 
and the other proteins involved in the experiment. 
 Additionally, helicase activity can be monitored by an SSB probe. Helicase 
activity is important in HR. Helicases are used in the resecting of the two broken 
ends of the damaged double stranded DNA (dsDNA), as well as in strand 
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invasion of the ssDNA overhangs. An SSB probe could function to monitor 
helicase activity, as SSB binds to the freshly unwound ssDNA. 
Plasmodium falciparum is a eukaryotic parasite, and can cause malaria in 
humans. This organism also creates its own version of the single-stranded DNA 
binding protein, PfSSB. This eukaryotic SSB shares similarity to EcSSB, in that it 
forms a tetramer in solution74. Likewise, the manner in which ssDNA wraps 
around PfSSB can be related to the seams along the outside of a tennis ball (Fig. 
19). The protein has a binding core responsible for the ssDNA binding behavior. 
Significantly, PfSSB does not display salt-dependent binding modes75. PfSSB 
binds around 65 nucleotides, regardless of salt concentration. This allows for 
data to be gathered reliably across a wide range of salt concentrations.  
Plasmodium falciparum SSB has one cysteine residue on each subunit of the 
tetramer, residing at its DNA binding core, making it a good candidate for 
fluorescent labeling with a maleimide fluorophore. Maleimide fluorescent labeling 
was discussed in Chapter 2. In the solved crystal structure of PfSSB74 (Fig. 19), 
this cysteine residue is near the ssDNA-binding region and on the protein's 
surface. Maleimide chemistry is fast and specific for thiols. Unbound, surface 
exposed cysteine residues contain a sulfhydryl group that reacts with the carbon-
carbon double bound of the maleimide group to directly link the side chain with a 
maleimide fluorophore. 
With one solvent exposed cysteine residue, and the display of only one 
type of ssDNA binding mode, PfSSB makes a good candidate for a novel probe  
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in studying HR dynamics. Because PfSSB binds to ssDNA at a similar ratio 
regardless of NaCl concentration, the amount of NaCl in a given experiment can 
be adapted for the specific proteins involved, allowing for greater flexibility in 
potential experiments. 
3.3 Materials and Methods 
3.3.1 PfSSB Purification 
The sequence for the PfSSB gene was previously incorporated into a 
pET21 vector. The pET21 vector contains ampicillin resistance as well as a t7 
promoter for inducible protein expression. The vector was transformed into 
Rosetta™(DE3)pLysS Competent Cells (Novagen) for protein expression. The 
Figure 19 | PfSSB binding to ssDNA. Observed to the left is the crystal 
structure for the PfSSB tetramer (PDB, 3ULP), with subunits in blue, red, 
yellow, and green, bound with two short strands of dT35 ssDNA (orange). The 
manner in which ssDNA tightly wraps around PfSSB is compared to the 
seams along the surface of a tennis ball.  
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cells were grown up in 1L Luria Broth (LB) with 100 μg/mL ampicillin, shaken at 
37ºC and 250 RPM. Purification steps can be seen in Figure 20. At an optical 
density, measured by a spectrophotometer at 600 nm (OD600), of 0.6, 
transcription was induced by the addition of 400 μM Isopropyl β-D-1-
thiogalactopyranoside (IPTG). After three additional hours of shaking, the growth 
was spun down at 4,000 RPM for 30 minutes and the cell pellet stored at -80ºC. 
Cell pellets containing the PfSSB protein were re-suspended in 200 mL of lysis 
buffer (10% sucrose, 50 mM Tris pH 8.3, 1 mM EDTA, 0.2 M NaCl, and 15 mM 
Spermidine), along with 100 μM phenylmethanesulfonyl fluoride (PMSF) 
dissolved in isopropanol. The resuspension was transferred to a beaker, and 
mixed on a stir plate at 4ºC for 10 minutes. Afterward, fresh lysozyme (Hen egg 
white) was added to a final concentration of 20 mg/100 mL. PMSF was added a 
second time, to a final concentration of 200 μM. The solution was then stirred at 
4ºC for another 30 minutes. Next, 6 mL of 100 mM sodium deoxycholate, 
dissolved in 0.125 M NaOH, was added. This was followed by 20 minutes of 
stirring at 4ºC.  
Sonication followed to thoroughly lyse the E. coli cells. The sonicator was 
set to 50% duty cycle. Cells were sonicated for one minute, followed by one 
minute of rest. This was repeated twice for a total of three minutes of sonication. 
The resulting cell lysate was centrifuged at 13,000 RPM for 80 minutes. 
A Polimin P precipitation was performed with the supernatant. A Polimin P 
solution [5% volume/volume Polimin P HCL, pH 8.3 and 10% volume/volume of 
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50% weight/volume Polyethylenimine (PEI)] was added, slowly, to a final 
concentration of 0.2% Polimin P, while being continuously stirred at 4ºC. After 15 
minutes, the solution was centrifuged for 30 minutes at 10,000 RPM. The pellet 
was then resuspended in 225 mL of 0.4 M NaCl Buffer T (5% glycerol, 50 mM 
35 
70 
55 
25 
15
 
10 
kDa 
PfSSB 
Figure 20 | PfSSB purification gel. A 12% SDS 
PAGE gel was ran, including uninduced and induced 
protein expression, as well as the supernatant and 
pellet from each purification step. Purified PfSSB can 
be viewed in the final, ammonium sulfate pellet lane. 
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Tris pH 8.3, 1 mM EDTA, and 0.4 M NaCl), and stirred at 4ºC for 25 minutes. 
This resuspension was again centrifuged for 30 minutes at 10,000 RPM.  
To the supernatant, 30.8% weight/volume of ground Ammonium Sulfate 
crystals were added. This was performed slowly, over a 15 minute period, while 
the solution was stirring at 4ºC. This concentration of ammonium sulfate forces 
the PfSSB protein to be salted out of the solution so that, after stirring for an 
additional 30 minutes, the protein can be collected by centrifugation. After 
spinning for 30 minutes at 10,000 RPM, the Ammonium Sulfate pellet was 
resuspended in 200 mls of 0.3 M NaCl Buffer T (5% glycerol, 50 mM Tris pH 8.3, 
1 mM EDTA, and 0.3 M NaCl). One additional centrifugation, again at 10,000 
RPM for 30 minutes, was performed in order to remove insoluble impurities. 
The next step in purifying of the PfSSB involved the use of a 125 mL 
ssDNA column. The ssDNA column was equilibrated with 100 mL 0.3 M NaCl 
Buffer T, to ensure that the column would be under the same buffer conditions as 
the resuspended protein. The protein was then loaded at 1mL/min onto the 
column, which was washed with 100 mL 0.3 M NaCl Buffer T. Next, a salt 
gradient was ran through the column to elute the bound protein. The elution 
buffer changed linearly from 100% to 0% 0.3 M NaCl Buffer T, as well as 0% to 
100% 2.0 M NaCl Buffer T, with a total volume of 200 mL. The column was ran at 
1mL/min. A following 10% SDS PAGE gel indicated which elutions contained the 
SSB protein.      
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The protein was concentrated in a 10 kDa Macrosep Advance 
concentrator (Pall Corporation), down to 3.5 mL. After measuring the 
concentration, the solution was dialyzed into Labeling Buffer (10% glycerol, 0.5 M 
NaCl, 30.75 mM K2HPO4, and 19.25 mM KH2PO4) overnight. The protein was 
flash-frozen with liquid nitrogen and stored at -80ºC for future labeling.         
3.3.2 PfSSB Fluorescent Labeling 
5mg/mL TCEP [(Tris)2-carboxyethyl]phosphine hydrochloride] was 
prepared in labeling buffer, and then added to the protein in a 16-fold molar 
excess. TCEP is a reducing agent, and is capable of reducing disulfide bonds. 
This is necessary as the thiol containing side chains of cysteine residues must be 
unbound so they can react upon mixing with the maleimide fluorophore.  The 
protein was labeled in a 10-fold molar excess with the specific fluorophore 7-
Diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (MDCC) (Life 
Technologies). 1 mg of dye was suspended in 200 μL dimethyl sulfoxide 
(DMSO), giving 13.04 mM MDCC. 160 μL of suspended dye was then added to 
the protein, with a final concentration of 2.98 mM MDDC for the labeling reaction. 
The tube was then covered in aluminum foil and placed on a rocker set to 15 
RPM at 4ºC overnight. 1.25 μL of 2-Mercaptoethanol (BME), resulting in a 5-fold 
molar excess of 14.9 mM, was added to quench the reaction the following 
morning. BME works to quench the reaction as the thiol group competes with the 
side chains of free cysteine residues to react with the maleimide group. 
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PfSSB-MDCC was then separated on a P-4 Bio-Gel (Bio-Rad) size 
exclusion column with Labeling Buffer. Collected protein was spun down to 0.5 
mL in a 10 kDa concentrator (Pall Corporation). Labeled protein was dialyzed 
over the weekend into SSB Storage Buffer (50% glycerol, 20 mM Tris, pH 8.3, 1 
mM EDTA, 0.5 M NaCl, and 1 mM BME). Labeled protein can be observed in 
both a coomassie and fluorescence image of the same 10% SDS PAGE gel (Fig. 
21). Figures 21-25 incorporate images previously published by the author in 
PLoS ONE.76 
After dialysis, the volume of Pf SSB-MDCC was 1.7 mL. Measuring the 
concentration of the fluorophore portion of the flow-through revealed  
two absorbance peaks, one peak near 430 nm and one peak near 270 nm, with 
the ratio of the magnitude of absorbance at these two peaks being approximately 
1: 0.3634 (430 nm peak : 270 nm peak). While measuring the concentration of 
protein, the absorbance at 270 nm exhibited by the fluorophore must be 
accounted for, as this adds to the absorbance of the protein peak near 270 nm. 
Therefore, when an apparent PfSSB-MDCC concentration of 56 μM for the 
tetramer is observed, the actual concentration is calculated to be 35.69 μM.  
3.3.3 Annealed DNA  
As the SRS2 protein prefers binding to 3′ single stranded overhangs77, an 
oligonucleotide, consisting of 25 nucleotides of double stranded DNA with a 16 
nucleotide 3′ single stranded overhang was prepared by annealing two partially 
complementary strands of ssDNA. One strand was 25 nucleotides in length, and  
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was complementary to the 5′ end of the other, 41 nucleotide strand. 1 μM 
concentrations of each strand were annealed in 20 mM Tris-HCl pH 8.0 and 50 
mM NaCl. 
 
Figure 21 | Labeling PfSSB. Purified and labeled 
PfSSB-MDCC is imaged with coomassie staining and 
fluorescence. This data has been previously 
published.76 
70 
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Stopped flow Instrumentation 
Stopped flow technique is discussed in Chapter 2.  
3.4 Results and Discussion 
3.4.1 PfSSB-MDCC Assays 
The usefulness of the PfSSB probe is determined by how well it functions 
as a monitor, indicating when free ssDNA is available in a system. In order to 
investigate the quality of the PfSSB probe, the probe must initially be 
characterized. Afterwards, the probe may be used to study different proteins in 
HR. 
The labeled probe exhibits an excitation peak near 430 nm and an 
emittance peak near 475 nm. Therefore an excitation wavelength of 430 nm was 
used in fluorescence-measuring experiments (Fig. 22a). The probe must exhibit 
a change in fluorescence upon binding to ssDNA, otherwise it is not revealing 
when ssDNA is unbound. The probe by itself has a significant fluorescence 
signal in the absence of ssDNA (Fig. 22b). However, when mixed with dT70 
ssDNA, nearly a fourfold increase in fluorescence is seen at 475 nm. This 
change in signal intensity demonstrates that the probe is sensitive to available 
ssDNA. 
Next an experiment was ran with the use of fluorimeter instrumentation 
with ratios of PfSSB probe to dT70 of 0 to 1.6 (Fig. 22c). As would be expected for 
a tetramer that binds 65 nucleotides of single stranded DNA, the fluorescence  
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Figure 22| PfSSB probe fluorescence and binding ratio. a, Observed are the 
excitation and emission wavelengths for the PfSSB-MDCC probe. b, The 
difference in fluorescence intensity of the probe alone in buffer, and when it 
binds to a strand of ssdT70 DNA, is nearly fourfold. c, The binding of PfSSB-
MDCC to ssdT70 essentially ceases when there are equal parts of both probe 
and filament, displaying how one PfSSB-MDCC tetramer binds to one sequence 
of dT70.  The data and images from 22a and 22c have been previously published 
in PLoS ONE.76      
 
c b 
a 
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plateaued once a ratio of one unit of tetramer to one unit of dT70 was reached. 
This displays that the probe binds only one length of dT70 at a time, and that 
there is only one tetramer per unit dT70. 
As noted earlier, previous SSB probes show differing binding modes of the 
SSB tetramer, dependent upon NaCl concentration. Since PfSSB has only one 
binding mode75, the PfSSB probe should bind to the same number of nucleotides 
of ssDNA at various NaCl concentrations. Figure 23a displays fluorimeter data of 
the probe, ran under the same conditions as done previously (Fig. 22c), but with 
NaCl concentrations of 0.01 M, 0.1 M, 0.50 M, and 1.0 M. These differing 
conditions all indicate the same binding mode, with the fluorescence signal 
saturating at a ratio of 1 PfSSB probe to 1 length of dT70 ssDNA. In Figure 23b, 
the binding stoichiometry from the experiment is more clearly displayed. In every 
condition of NaCl concentration, the binding stoichiometry remains near one. 
In order to further characterize the probe, Stopped flow assays were 
performed with 20 nM PfSSB in one sample, and increasing concentrations of 
dT70 (25 nM, 50 nM, 100nM, 250 nM, and 400 nM) in the other (Fig. 24a.). To 
acquire the observed rate of PfSSB binding to dT70, the data was fit using a 
single exponential equation. The single exponential fit equation is as follows: 
At= A0e-kt 
In this equation, A0 is fluorescence (or bound dT70) at time zero, At is 
fluorescence (or bound dT70) at time t, k is the observed rate constant and t is 
time. Graphing the observed rate constant against the concentration of dT70 
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results in a linear plot (Fig. 24b). The slope of this plot provides the rate of 
association, 2.6 x 10^8 M-1s-1. This demonstrates that the probe binds ssDNA 
quickly, fulfilling a necessary requirement of sensitivity for free ssDNA. To be 
functional in studying HR, the probe must bind ssDNA at a fast rate, out 
competing potential ssDNA-reactive molecules, including the scenario where the 
ssDNA self-anneals. As SSB works to protect free ssDNA from damage and self-
annealing in nature, the tetramer can bind quickly enough to prevent these 
potentially hindersome outcomes from happening. 
Now that the probe has been characterized, it may be utilized as a tool in 
the study of HR proteins. One such experiment was performed, with the use of 
Stopped flow instrumentation, to monitor the disassembly of the Rad51-ssDNA 
Figure 23 | PfSSB-MDCC exhibits a single binding mode. a, For 
differencing concentrations of NaCl, fluorescence is observed against the 
number of PfSSB tetramer probes, divided by the number of dT70 molecules. 
b, For all four NaCl concentrations, a plateau in fluorescence is observed 
once the number of PfSSB tetramer probes, divided by the number of dT70, 
equals roughly one. This indicates that PfSSB exhibits only one binding 
mode. The data and images found here have been previously published.76 
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filament by the SRS2 anti-recombinase protein. The initial condition was 
performed by mixing 75 nM of PfSSB probe with 3uM M13mp18 plasmid ssDNA 
(New England Biolabs). Rad51 Clearing Buffer (25 mM Tris-HCl pH 7.7, 1 mM 
DTT, 5% glycerol, 10 mM MgCl2, and 50 mM NaCl) was used in all trials. As 
expected, a quick increase in fluorescence signal was seen as the probe bound 
residues of free ssDNA (Fig. 25a).   
In the next condition, the probe was mixed with M13mp18 plasmid, which 
had been pre-incubated with 1.5 μM Rad51 and 2.85 μM ATP (Fig. 25b). As the 
Rad51 filament forms and is already bound to the ssDNA, no significant increase 
in signal was observed upon mixing. As the probe is not signaling for ssDNA 
binding, the Rad51 protein is not being replaced by the PfSSB. The observation 
Figure 24| Determining the rate of association of PfSSB-MDCC. a, The 
initial rate of PfSSB binding to dT70 DNA is observed at differing DNA 
concentrations. b, Fitting each concentration of dT70 to a single exponential 
provides the observed rate. Plotting the observed rates against substrate 
concentration gives a linear plot, the slope of which provides a rate of 
association, 2.6 x 108 M-1s-1. These images have been previously published in 
PLoS ONE.76 
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Figure 25 | SRS2 Rad51 clearing experiment. a, The probe binds quickly to 
m13ss plasmid DNA. b, A pre-formed Rad51 filament on the M13mp18 
plasmid ssDNA is not replaced by PfSSB. c, When SRS2 anti-recombinase 
protein is added along with the probe to the preformed Rad51-DNA filament, 
Rad51 is removed by SRS2 and replaced with the PfSSB probe on the 
plasmid. These images have been previously published.76                                            
c
a 
a 
b 
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that PfSSB does not remove the Rad51 filament is essential, otherwise the probe 
could not act as a reliable reporter on how other HR proteins disassemble Rad51 
from ssDNA.  
Finally, (now that it is known that the probe does not, at least on its own, 
remove the Rad51 filament), a condition was ran to study the activity of the SRS2 
anti-recombinase. In this trial, the PfSSB probe, as well as 200 nM SRS2, were 
mixed with the pre-incubated Rad51, ATP, and M13mp18 ssDNA plasmid (Fig. 
25c). A steady increase in fluorescence intensity is seen as SRS2 moves along 
the ssDNA plasmid, removing the Rad51 filament. The probe, with the previously 
determined rate of association of 2.6 x 108 M-1s-1, is able to bind to the ssDNA 
after the dissociation of Rad51. SRS2 has been shown to remove Rad51 from 
ssDNA at a rate of approximately 12 nucleotides s-1 37. 
The more time SRS2 is allowed to remove Rad51, the more signal 
intensity, and thus the more binding of PfSSB, is observed. This experiment 
provides supporting evidence for SRS2's role as an anti-recombinase in HR, and 
that the PfSSB probe can be used to study the disassociation of Rad51 bound to 
ssDNA. Hence the probe is seen as a successful tool for the study of HR 
proteins. 
3.4.2 SRS2 DNA Unwinding  
The next experiment performed with PfSSB focused on the helicase 
activity of SRS2, rather than its function as an anti-recombinase. A model of the 
experiment can be seen in Figure 26. As previously noted, helicase activity is a  
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Figure 26 | A model for the SRS2 DNA unwinding experiment. a, SRS2 is 
pre-incubated with DNA, with 25 double stranded nucleotides attached to a 16 
nucleotide single-stranded overhang. The SRS2 loads onto the ssDNA. b, Upon 
mixing with excess ATP and two-fold excess PfSSB, SRS2 begins to unwind 
the dsDNA. c, The PfSSB probe binds to the newly freed ssDNA, and 
undergoes a change in fluorescence intensity. d, Due to the two-fold excess of 
PfSSB, both of the resulting ssDNA molecules can be bound. 
 
a b 
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vital component of homologous recombination. As PfSSB binds to ssDNA, it can 
be used to monitor when a helicase unzips dsDNA, resulting with two ssDNA 
strands that are free to bind to PfSSB. With the use of Stopped flow 
instrumentation, a solution of 160 nM wild type SRS2 protein, 2.85 μM ATP and 
40 nM annealed dsDNA, with a 3′ ssDNA overhang, was mixed with a solution of 
80 nM PfSSB. DNA Unwinding Buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
and 50 mM NaCl) was used in all conditions. SRS2 binds to ssDNA overhangs77, 
and translocates with 3′ to 5′ directionality16. 
These conditions were repeated once with a no ATP control, and once 
more with an SRS2 containing a DK-AA mutation in its 2B domain. This mutated 
protein was used to test if the changed residues will alter SRS2 DNA unwinding 
activity, as was observed in a homologous helicase, UVRD78.  
In the no ATP control, only a very slight increase in fluorescence intensity 
was observed (Fig. 27). This indicates that SRS2 does not unwind the dsDNA in 
the absence of ATP, and that the PfSSB probe does not work to displace the 
SRS2 from its position on the single-stranded overhang of the DNA. Some 
increase in fluorescence can be accounted for as SRS2 slowly dissociates from 
the single stranded overhang, which is then bound by PfSSB.                                                                                                                                
For both trials including ATP, the SRS2, utilizing ATP as an energy 
source, unwinds the dsDNA. This results in the large, quick increase in 
fluorescence by the PfSSB probe (Fig. 27). As both versions of the protein show 
similar cleavage data, the results of this experiment indicate that the mutation 
72 
 
 
 
 
 
 
 
does not alter the DNA unwinding activity of SRS2. While no significant 
difference was found in helicase activity between the two SRS2 proteins, this 
experiment does demonstrate that the labeled tetramer works as a probe for 
helicase activity, which is a crucial component of homologous recombination. 
3.5 Future Work 
 This probe could function in further studies on HR mediator proteins, 
especially those which either promote or hinder the removal of the Rad51 
Figure 27 | SRS2 DNA unwinding data. Displayed are the results from 
a Stopped flow experiment. One of the samples to be mixed contains 
SRS2, pre-loaded onto dsDNA with a ssDNA overhang, while the other 
the contains the PfSSB probe and ATP. Two variants of the SRS2 
protein were investigated, the wild type and the AA-DK 2B domain 
mutant.                                                                                                                                                                                                                                                                                                                                                                                                                                          
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filament, to indicate how fast ssDNA is becoming available in a system. 
Additionally, helicases, and other proteins that effect helicase function, can be 
investigated utilizing the fluorescently labeled PfSSB. As  
the probe does not change binding modes, experiments can be ran at various 
concentrations of NaCl.  
The assays performed here characterize the probe, and provide examples 
of how it can both function to monitor the removal of Rad51 from ssDNA, as well 
as the unwinding of dsDNA. Working to monitor Rad51, as well as the HR protein 
SRS2, demonstrates that this probe can function as a tool in the further study of 
HR.  
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CHAPTER IV 
SUMMARY 
Rad51, the primary machinery for HR, is critical for genome maintenance. 
The up-regulation of Rad51 and HR can lead to excessive genetic 
rearrangements, causing genomic instability. Likewise, down-regulation can lead 
to an accumulation of double-strand breaks. Both of these scenarios can be 
harmful to the cell. The proper balance of HR and Rad51 is key, various cancers 
have demonstrated either up or down regulation of Rad51. This stresses the 
importance of studying the proteins involved in mediating the Rad51-DNA 
filament in HR, particularly where the specific function and mechanism of many 
Rad51 filament mediator proteins is largely unknown. 
To increase the understanding of these mediator proteins, this work has 
developed a toolkit of protein-probes. These proteins are directly attached to 
fluorophores at specific amino acid residues. While a common technique in 
studying HR proteins involves the use of DNA labeled with a terminal 
fluorophore, labeled proteins can provide a signal at essentially every occurrence 
of a DNA-protein interaction. This provides greater experimental detail in the 
study of how different proteins effect the Rad51-DNA filament. 
In the making of this tool kit, probes were first developed from ScRad51. 
This was completed in accordance with Aim 1: Create a probe for the Rad51-
DNA filament by incorporating the unnatural amino acid 4-amino-l-phenylalanine 
in place of specific amino acid residues in Saccharomyces cerevisiae Rad51.  
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Successful incorporation of 4AZP was performed at various positions of 
Rad51’s loops L1 and L2. The Rad51-4AZP-fluropohre Stopped flow assay 
preliminary results indicate a change in fluorescence emission intensity upon 
protein-ssDNA filament formation with probes located at positions 290, 291, and 
337. This is in line with Aim 1a: Specifically investigate positions on loops L1 and 
L2 of ScRad51 which, following labeling with an alkyne fluorophore, will result in 
fluorescently labeled protein which displays a change in fluorescence emission 
intensity upon filament formation.  
Further locations on loops L1 and L2 can be investigated in future work to 
find a greater signal change upon DNA binding. Future work can also optimize 
these probes through increased labeling efficiently. Different click fluorophores 
will be tested at various temperatures and durations.  
The size and shape of individual fluorophores could also impact the 
change in fluorescence emission intensity upon filament formation, as well as 
effect Rad51 activity levels. While the labeled probes may undergo an 
observable change in fluorescence emission intensity upon binding to DNA, 
protein activity levels should not be altered for the probes to accurately report 
Rad51 filament dynamics. If a fluorophore is too bulky and inhibits filament 
formation, the probe would not perform activity at the same level as the wild type. 
 While it has been displayed that 4AZP incorporation does not alter 
filament formation on Cy3 labeled dT79 ssDNA, further work will be performed to 
measure the activity levels of the Rad51 probe with a fluorophore bound. This will 
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be measured with the utilization of electrophoretic mobility shift assays (EMSA). 
Here, Rad51 probes and wild type Rad51 will be evaluated with the use of DNA 
oligomers. The first oligomer will be a short, single strand of DNA radiolabeled 
with 5′ phosphorous-32 (P-32). P-32 is a radioactive isotope, undergoing beta 
decay to convert to sulfur-32.  
 Another oligomer will consist of a large, circular plasmid, with a section of 
sequence complimentary to the first small strand. This plasmid will be annealed 
to another short strand with the exact same sequence as the radiolabeled DNA, 
and without the P-32 label.  Rad51 will perform strand exchange activity with the 
two short oligomers, replacing the oligomer attached to the plasmid with the P-32 
version. The reaction will be quenched at given time points, and samples ran on 
a polyacrylamide gel. If strand exchange has occurred, the P-32 label can be 
attached to the large plasmid, appearing in an upper (greater mass) band on the 
gel. If strand exchange activity is lowered for the Rad51-4AZP probes, a greater 
amount of the P-32 label will be seen in a lower (lesser mass) band for the same 
time points. This corresponds to the short P-32 sequence of DNA that has not 
been exchanged onto the plasmid. By performing the assay with differing 
concentrations of substrate DNA, rates for strand exchange activity could be 
obtained for the wild type and 4AZP incorporated proteins. 
 After labeling efficiency has been optimized and activity levels for the 
probes have been determined to be equivalent to the wild type, further 
experiments may be performed. Ideally, the probes with fluorophores positioned 
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on loops L1 and L2 can be used to monitor the effects of HR mediator proteins 
on the Rad51 filament. For these experiments to proceed, the probes will be 
mixed with DNA, along with a given mediator protein such as Rad52.  
Rad52 promotes the replacement of RPA with Rad51 on DNA36. A future 
experiment could be performed by mixing DNA already bound by RPA with 
Rad51 and Rad52 in a Stopped flow apparatus. A change in fluorescence 
emission intensity should be observed as the Rad51 replaces RPA and forms a 
filament with DNA. This could potentially reveal a rate for the replacement of 
RPA by Rad51 in the presence of Rad52.   
 Additional experiments could be performed in a similar manner, but 
instead with Rad51 pre-incubated on DNA and mixed with RPA and SRS2. As 
SRS2 disassociates the Rad51 filament, allowing RPA to bind in its place, a rate 
for Rad51 filament removal by SRS2 could be obtained by performing the 
experiment at various Rad51-DNA filament concentrations.  
 While current techniques utilize short strands of DNA with a terminal 
fluorophore, large lengths of DNA, such as plasmids, can be studied with these 
probes. This is significant, as Rad51 filaments form on long strands of DNA in 
nature when they repair the double-strand breaks of a chromosome. Instead of 
having an end reporter of the Rad51-DNA interaction, reporters are present at 
every location of interaction between DNA and Rad51. With labeled DNA, any 
nearby protein may cause a change in fluorescence intensity. By labeling 
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proteins instead of nucleotides, information can be gathered on which specific 
protein is bound. 
A probe has been positioned near the N-terminus of Rad51 (16-4AZP), in 
the pursuance of Aim 1b: Develop a UAA probe with a fluorescent label near the 
N-terminus of ScRad51, to be used for future FRET and single molecule designs. 
The same techniques will be performed to optimize labeling efficiency and check 
the level of activity. Next, FRET experiments could be performed where 50% of 
the protein is labeled with one member of a FRET pair, while 50% of the protein 
is labeled with the other. This experiment would display when a filament has 
been formed, with a high FRET signal, as the FRET pair fluorophores are close 
enough to each other in the filament to undergo FRET. Likewise, filament 
disassembly can be observed by a decrease in FRET signal. This experimental 
design is further expounded upon in Chapter 2. 
In addition to the FRET experimentation, future work can also utilize this 
probe for single molecule studies. As the position of the fluorophore is on the n-
terminal domain, away from the sites of DNA and ATP binding, this probe should 
not interfere with protein activity, (though this will still be checked with the EMSA 
discussed previously). If the labeled probe is allowed to form on an isolated 
strand of DNA, the use of a total internal reflection fluorescence (TIRF) 
microscope might provide high detail images of the Rad51-DNA filament. This 
could provide insights into nucleation and the exchange of RPA for Rad51, as the 
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images would spatially display were the labeled probes are situated during the 
different steps of HR.  
Additional success has been seen with the development of a fluorescently 
labeled probe from Plasmodium falciparum SSB. As this probe wraps DNA very 
tightly, it can act as a reporter for when free single stranded DNA becomes 
available with a near fourfold increase in fluorescence intensity. 
The PfSSB probe is simple to make; no amino acid residues must be 
changed via mutation in order to produce the probe. This leaves the protein 
unaltered, save for the addition of a fluorophore at a lone cysteine residue. 
PfSSB, unlike EcSSB, displays only one salt-dependent binding mode where it 
binds roughly one unit of dT70 per unit tetramer. This provides an advantage in 
experiments, as salt conditions do not have to be regimented to insure the quality 
of results.  
The binding constant of this probe was calculated to be 2.6 x 108 M-1s-1, 
demonstrating that ssDNA will be bound very quickly in reactions. Thus, this 
probe can be useful in Stopped flow experimentation, where millisecond-scale 
measurements are taken upon mixing two solutions. Such is the case in our 
experiment where a pre-formed Rad51 filament is cleared by SRS2 from ssDNA, 
allowing the SSB probe to bind in its place and exhibit a corresponding increase 
in fluorescence signal. We have also displayed that the probe can be used to 
monitor helicase activity. This probe works in accordance with Aim 2: With 
Plasmodium falciparum single strand DNA binding protein (SSB), develop a 
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probe which, when labeled with a maleimide fluorophore, will act as a signal for 
unbound, single stranded DNA (ssDNA) by undergoing a change in fluorescence 
emission intensity upon binding.    
While this work utilized the PfSSB probe for studying the anti-recombinase 
protein SRS2, other HR proteins could also be investigated. Future 
experimentation with the PfSSB probe could study the Shu complex, which 
promotes homologous recombination. The ability of the Shu complex to 
potentially alter the rate of Rad51 filament removal by anti-recombinase proteins 
such as SRS2 could be examined. 
In this work, protein-fluorophore probes have been developed for purpose 
of studying Rad51 filament dynamics. Advancing the current techniques available 
to investigate homologous recombination can help further the current 
understanding of the interactions between Rad51 and HR mediator proteins. The 
association of cancers with altered HR levels makes the topic all the more 
relevant. Revealing the mechanisms and function of these mediators could help 
indicate directions for future therapeutic approaches in the treatment of cancers 
and associated genetic disorders.   
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Supplemental Figures 
 
 
 
Supplemental Figure 1 | 4AZP NMR. Displayed above is the C13 NMR of our 
product, 4-azido-l-phenylalanine (4AZP). Some DMF is still seen with the product, 
otherwise the sample exhibits high purity.  
 
 
